PPIDT00244
Drug Information
| Name | Ocriplasmin |
|---|---|
| Sequence | APSFDCGKPQVEPKKCPGR |
| DrugBank_ID | DB08888 |
| Type | biotech |
| Indication | Ocriplasmin is a proteolytic enzyme indicated for the treatment for symptomatic vitreomacular adhesion. |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, solution | Intravitreal |
0.375 MG/0.3ML
|
| Injection, solution | Intravitreal |
1.25 mg/1mL
|
| Injection, solution | Intravitreal |
2.5 mg/1mL
|
| Injection, solution, concentrate | Intravitreal |
0.5 mg/0.2ml
|
| Solution | Intravitreal |
1.25 mg / mL
|
| Solution | Intravitreal |
2.5 mg / mL
|
| Solution, concentrate | Intravitreal |
0.5 MG/0.2ML
|